[1] Retatrutide (trials): once-weekly subcutaneous administration, starting low (e.g., 2 mg) and escalating to 4, 8, or 12 mg maintenance, with slower titration used to improve tolerability
a further subject of the present invention consists in pharmaceutical and/or dietetic compositions containing as their active ingredient acetyl L- carnitine, propionyl L-carnitine, or one of their pharmaceutically acceptable salts, in combination with one or more of said drugs useful for the treatment of erectile dysfunction, and at least one pharmaceutically acceptable excipient and/or diluent
7, July 2018, pp
After this treatment, the abundance of antibiotics treated mice were with Klebsiella , Ochrobactrum and Enterobacteriaceae , and untreated mice were with Bacteroides , S24-7 , and Clostridia_Clostridiales